RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast CancerTian-Hao Weng, Hangping Yao|Cancer Research and Treatment|2020Cited by 64